Skip to content

Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis

Unknown statusNot applicableNCT02964000
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Hypothesis: Use of high level vs low level cold laser treatments will reduce chronic pain and the need for PRN opioid-containing analgesic medications. Secondary Hypothesis: High level (vs low level) laser treatments will increase the patients level of physical activity and quality of sleep.

Study details

Official title
Adjunct Use of the Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid-containing Medication on a PRN Basis
Conditions
Interventions
  • Device: Low level 1 Watt
  • Device: Phoenix Thera-Lase System 42
  • Device: Phoenix Thera-Lase System 74
Sponsor
Phoenix Thera-lase Systems, LLC
Start date
2016-11
Primary completion
2017-12
Sex
All
Age range
from 25 Years to 65 Years
Results posted
No results posted in this snapshot
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male or female patients * 25-65 years of age * taking oral opiate-containing analgesic medication on a PRN * patient with chronic pain related to an accident, injury or major surgery occurring within the past three years * Patients with a potentially treatable pain condition * Patient wiling to complete a daily diary for recording their pain score, activity level, quality of sleep and all pain-related medications for the three-week study period Exclusion Criteria: * Use of any opioid-containing pain medications for more than three years * History of alcohol or drug abuse, or drug-seeking behavior * Previous treatment for drug abuse in detox center or hospital * Current psychiatric condition which require centrally- active medications * Current excessive use of alcohol * Any unstable medical conditions (e.g. coronary artery disease, hepato-renal or pulmonary disease) * Patients not capable of consenting for themselves * Pregnant women * Women of child bearing potential not using acceptable birth control methods.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02964000